High-Yield LeukoCore™ Chronic Kidney Disease Leukopaks for Inflammatory Research

LeukoCore™ Chronic Kidney Disease (CKD) Leukopak biospecimens are collected from donors clinically diagnosed with Chronic Kidney Disease (CKD) through IRB-approved apheresis procedures. Each human leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for immune profiling, cytokine analysis, and drug development research related to Chronic Kidney Disease (CKD) inflammation and immune dysregulation.

Product Features

• Research Use Only (RUO) human chronic kidney disease leukopaks
• Clinically confirmed CKD donors
• High cell yield for large-scale studies
• Processed and shipped within 24 hours of collection
• Fresh or cryopreserved options available
• IRB-approved and ethically sourced
• Infectious disease testing
• HLA-A typing
• Screen donors with LeukoLot™

Donor Metadata

• Verified CKD diagnosis from healthcare providers
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported medication history and allergies
• Relevant clinical data including CKD severity (if available)

Applications

• Immune cell characterization in CKD
• Therapeutic development and screening
• Cell-based assays and cytokine profiling
• Multi-omics studies including single-cell sequencing

Compliance and Quality Assurance

• Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
• HIPAA-compliant handling of donor information
• Rigorous donor screening and documentation

Ordering & Customization

Chronic Kidney Disease Human Leukopak samples are available fresh or cryopreserved. For international shipping or regulatory documentation, please contact to confirm regional compliance and shipping availability.